有机酸性病的基因疗法:从甲基和酸性酸性病中学到的教训
Randy J Chandler1, Charles P Venditti1
1National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Journal of inherited metabolic disease
|August 2, 2023
概括
基因疗法为有机酸性病 (OA),罕见的代谢障碍提供了一个有前途的新疗法. 用小鼠模型进行的研究表明,在治疗这些严重疾病方面,可能有更广泛的应用.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 有机酸性病 (OA) 是一种罕见的自体逆性代谢障碍.
- 甲状腺炎导致全身有机酸升高,代谢不稳定以及多系统性并发症.
- 目前的治疗方法,包括饮食和辅助因子,对许多患者来说都不足.
研究的目的:
- 对有机酸性病的基因治疗方法进行审查.
- 为了说明实验范式,使用甲基马龙酸血症 (MMA) 和酸血症 (PA) 鼠标模型.
- 探索基因疗法的潜力,作为一种新的治疗OA.
主要方法:
- 在MMA和PA小鼠模型中对基因治疗实验的审查.
- 对治疗OA的实验范式的分析.
- 评估肝移植作为基因治疗的前身.
主要成果:
- 对OA的相关动物模型中已经探索了基因疗法方法.
- 已经使用MMA和PA小鼠模型来测试基因治疗策略.
- 这些模型中的实验范式可能适用于所有形式的OA.
结论:
- 基因疗法在治疗OA方面具有理论上的前景.
- 肝移植可以改善严重OA病例的代谢稳定性.
- 对动物模型的进一步研究对于开发有效的OA基因疗法至关重要.
相关概念视频
Inborn Errors of Metabolism
195
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
195
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
2.0K
Just like β-keto acids—which upon thermal decarboxylation form ketones—β-dicarboxylic acids undergo decarboxylation to generate monocarboxylic acids with the liberation of carbon dioxide.
2.0K
Alkylation of β-Diester Enolates: Malonic Ester Synthesis
3.4K
Malonic ester synthesis is a method to obtain α substituted carboxylic acids from ꞵ-diesters such as diethyl malonate and alkyl halides.
3.4K
Gene Therapy
25.5K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.5K
Phase II Reactions: Methylation Reactions
233
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
233
Amino Acid Biosynthetic Pathways
38
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
38


